A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.

Abstract:

:MicroRNAs (miRNAs) are small noncoding RNAs, thought to be involved in physiologic and developmental processes by negatively regulating expression of target genes. We have previously reported frequent down-regulation of the let-7 miRNA family in lung cancers and, in the present study, assessed alteration in a panel of 19 lung cancer cell lines. As a result, we found for the first time that the miR-17-92 cluster, which comprises seven miRNAs and resides in intron 3 of the C13orf25 gene at 13q31.3, is markedly overexpressed in lung cancers, especially with small-cell lung cancer histology. Southern blot analysis revealed the presence of increased gene copy numbers of the miRNA cluster in a fraction of lung cancer cell lines with overexpression. In addition, we were able to show predominant localization of C13orf25 transcripts within the nucleus and introduction of the expression construct of the miR-17-92 cluster, but not the putative open reading frame of C13orf25, enhancing lung cancer cell growth. These findings clearly suggest that marked overexpression of the miR-17-92 cluster with occasional gene amplification may play a role in the development of lung cancers, especially in their most aggressive form, small-cell lung cancer, and that the C13orf25 gene may well be serving as a vehicle in this regard.

journal_name

Cancer Res

journal_title

Cancer research

authors

Hayashita Y,Osada H,Tatematsu Y,Yamada H,Yanagisawa K,Tomida S,Yatabe Y,Kawahara K,Sekido Y,Takahashi T

doi

10.1158/0008-5472.CAN-05-2352

subject

Has Abstract

pub_date

2005-11-01 00:00:00

pages

9628-32

issue

21

eissn

0008-5472

issn

1538-7445

pii

65/21/9628

journal_volume

65

pub_type

杂志文章
  • Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.

    abstract::Emerging knowledge on how the dysregulated function of signaling networks contributes to the malignant growth of squamous cell carcinoma of the head and neck (HNSCC) can now be exploited to identify novel mechanism-based anticancer treatments. In this regard, we have observed that persistent activation of the serine/t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0921

    authors: Amornphimoltham P,Patel V,Sodhi A,Nikitakis NG,Sauk JJ,Sausville EA,Molinolo AA,Gutkind JS

    更新日期:2005-11-01 00:00:00

  • Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.

    abstract::Epithelial ovarian cancer comprises three major histological subtypes (serous, mucinous, and endometrioid), and it is becoming clear that the developmental pathways for these subtypes are fundamentally different. In particular, endometrioid ovarian cancers probably arise by the malignant transformation of ectopic endo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Obata K,Morland SJ,Watson RH,Hitchcock A,Chenevix-Trench G,Thomas EJ,Campbell IG

    更新日期:1998-05-15 00:00:00

  • Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts.

    abstract::The Ras proto-oncogene has been implicated in the in vivo development of tumors and in the in vitro transformation of cultured cell lines. In both of these conditions, Ras-mediated disruption of cell cycle-regulatory mechanisms leads to unregulated cellular proliferation, although the exact mechanisms by which Ras acc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: LaRue KE,Bradbury EM,Freyer JP

    更新日期:1998-03-15 00:00:00

  • Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling.

    abstract::We previously found that a Salmonella typhimurium vector engineered to secrete soluble tumor antigen induces CD4(+) T cells resistant to CD4(+)CD25(+) regulatory T cells (Treg) and that glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR) signal is involved in the development of this resist...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5839

    authors: Nishikawa H,Kato T,Hirayama M,Orito Y,Sato E,Harada N,Gnjatic S,Old LJ,Shiku H

    更新日期:2008-07-15 00:00:00

  • Identification of a human homologue of the murine tumor rejection antigen GP96.

    abstract::A family of cell surface glycoproteins with a molecular weight of 96,000 (gp96) has recently been implicated in the individually distinct immunogenicity of chemically induced sarcomas of inbred mice. Rabbit antiserum to murine gp96 detects an antigenically related Mr 96,000 cell surface glycoprotein on two cultured hu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Srivastava PK,Old LJ

    更新日期:1989-03-15 00:00:00

  • Cytoplasmic domain of proEGF affects distribution and post-translational modification of microtubuli and increases microtubule-associated proteins 1b and 2 production in human thyroid carcinoma cells.

    abstract::We studied the distribution of transcripts encoding the cytoplasmic domain of the membrane-anchored precursor epidermal growth factor (proEGFcyt) and a novel cytoplasmic proEGF splice isoform with a deleted exon 23 and an out-of-frame fusion of exon 24 (proEGFdel23) in human normal and neoplastic thyroid tissues. In p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2030

    authors: Pyka J,Glogowska A,Dralle H,Hoang-Vu C,Klonisch T

    更新日期:2005-02-15 00:00:00

  • HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.

    abstract::We reported that NK4, composed of the N-terminal hairpin and subsequent four kringle domains of hepatocyte growth factor (HGF), acts as the competitive antagonist for HGF. We now provide the first evidence that NK4 inhibits tumor growth and metastasis as an angiogenesis inhibitor as well as an HGF antagonist. Administ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kuba K,Matsumoto K,Date K,Shimura H,Tanaka M,Nakamura T

    更新日期:2000-12-01 00:00:00

  • SlicerDMRI: Open Source Diffusion MRI Software for Brain Cancer Research.

    abstract::Diffusion MRI (dMRI) is the only noninvasive method for mapping white matter connections in the brain. We describe SlicerDMRI, a software suite that enables visualization and analysis of dMRI for neuroscientific studies and patient-specific anatomic assessment. SlicerDMRI has been successfully applied in multiple stud...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-0332

    authors: Norton I,Essayed W,Zhang F,Pujol S,Yarmarkovich A,Golby AJ,Kindlmann G,Wassermann D,Estepar RSJ,Rathi Y,Pieper S,Kikinis R,Johnson HJ,Westin CF,O'Donnell LJ

    更新日期:2017-11-01 00:00:00

  • The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right.

    abstract::The immune system is a robust and often untapped accomplice of many standard cancer therapies. A majority of tumors exist in a state of immune tolerance where the patient's immune system has become insensitive to the cancer cells. Because of its lymphodepleting effects, chemotherapy has the potential to break this tol...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-3712

    authors: Park DS,Robertson-Tessi M,Luddy KA,Maini PK,Bonsall MB,Gatenby RA,Anderson ARA

    更新日期:2019-10-15 00:00:00

  • Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.

    abstract::The human small cell lung cancer NCI-H69 cell line selected for resistance to etoposide (H69/VP) has been reported previously to sequentially overexpress both the MRP and MDR1 multidrug resistance-conferring genes. In addition, immunocytochemistry of H69/VP cells demonstrated a distinct extranuclear localization of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wessel I,Jensen PB,Falck J,Mirski SE,Cole SP,Sehested M

    更新日期:1997-10-15 00:00:00

  • Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.

    abstract::Modest clinical outcomes of dendritic cell (DC) vaccine trials call for novel strategies. In this study, we have created a chimeric CD40 molecule that incorporates a single chain Fv (scFv) molecule specific for human ErbB2 antigen and fusing to the membrane spanning and cytosolic domains of murine CD40. After adenovir...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6051

    authors: Wei H,Wang H,Lu B,Li B,Hou S,Qian W,Fan K,Dai J,Zhao J,Guo Y

    更新日期:2008-05-15 00:00:00

  • Sequence-specific inhibition of DNA strand elongation by incorporation of 9-beta-D-arabinofuranosyladenine.

    abstract::9-beta-D-Arabinofuranosyladenine (ara-A) is an inhibitor of DNA replication with antitumor and antiviral activity. The molecular basis for this inhibitory effect has remained unclear. The present work has examined the effects of 9-beta-D-arabinofuranosyladenine-triphosphate on DNA polymerase-beta. These studies were p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ohno Y,Spriggs D,Matsukage A,Ohno T,Kufe D

    更新日期:1989-04-15 00:00:00

  • Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.

    abstract::p16Ink4 and p15Ink4B are cyclin-dependent kinase 4 inhibitors and link to the regulation of cell cycle in mammalian cells. The genes encoding these inhibitors are located at 9p21, which is a frequent site of allelic loss in various types of tumors. Twenty-five primary biliary tract cancers were examined for somatic mu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yoshida S,Todoroki T,Ichikawa Y,Hanai S,Suzuki H,Hori M,Fukao K,Miwa M,Uchida K

    更新日期:1995-07-01 00:00:00

  • A recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma results in replacement of the 5' regulatory region of BCL6 with a novel H4 histone gene.

    abstract::3q27 translocations affecting the BCL6 gene can involve not only immunoglobulin genes (IG) but also other as yet uncharacterized chromosomal loci as partners. Here, we describe cloning of the junctional area of a recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma of B-cell type and isolation of clones...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Akasaka T,Miura I,Takahashi N,Akasaka H,Yonetani N,Ohno H,Fukuhara S,Okuma M

    更新日期:1997-01-01 00:00:00

  • Effects of a high-sucrose diet on the development of enzyme-altered foci in chemical hepatocarcinogenesis in rats.

    abstract::Dietary factors can modify metabolic events involved in the initiation, promotion, or progression of tumors. To determine whether a high-sucrose diet has any effect on the development of enzyme-altered foci during the promotion step of chemical hepatocarcinogenesis in rats, 1-day-old Sprague-Dawley rats were given a s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hei TK,Sudilovsky O

    更新日期:1985-06-01 00:00:00

  • Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis.

    abstract::The cells of many solid tumors have been found to contain supernumerary centrosomes, a condition known as centrosome amplification. Centrosome amplification, accompanied by the overexpression of an associated kinase, Aurora A (AurA), has been implicated in mechanisms leading to mitotic spindle aberrations, aneuploidy,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Goepfert TM,Adigun YE,Zhong L,Gay J,Medina D,Brinkley WR

    更新日期:2002-07-15 00:00:00

  • Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice.

    abstract::This study describes a novel approach to the treatment of brain tumors with the combination of recombinant L-methionine-alpha-deamino-gamma-lyase and chemotherapeutic regimens that are currently used against such tumors. The growth of Daoy, SWB77, and D-54 xenografts in athymic mice was arrested after the depletion of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kokkinakis DM,Hoffman RM,Frenkel EP,Wick JB,Han Q,Xu M,Tan Y,Schold SC

    更新日期:2001-05-15 00:00:00

  • A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer.

    abstract::A chimeric CYCLIN D1-TROP2 mRNA was isolated from human ovarian and mammary cancer cells. The CYCLIN D1-TROP2 mRNA was shown to be a potent oncogene as it transforms naïve, primary cells in vitro and induces aggressive tumor growth in vivo in cooperation with activated RAS. Silencing of the chimeric mRNA inhibits the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6135

    authors: Guerra E,Trerotola M,Dell' Arciprete R,Bonasera V,Palombo B,El-Sewedy T,Ciccimarra T,Crescenzi C,Lorenzini F,Rossi C,Vacca G,Lattanzio R,Piantelli M,Alberti S

    更新日期:2008-10-01 00:00:00

  • Inhibiting DX2-p14/ARF Interaction Exerts Antitumor Effects in Lung Cancer and Delays Tumor Progression.

    abstract::The aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 (AIMP2) splice variant designated DX2 is induced by cigarette smoke carcinogens and is often detected in human lung cancer specimens. However, the function of DX2 in lung carcinogenesis is obscure. In this study, we found that DX2 expression w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-1025

    authors: Oh AY,Jung YS,Kim J,Lee JH,Cho JH,Chun HY,Park S,Park H,Lim S,Ha NC,Park JS,Park CS,Song GY,Park BJ

    更新日期:2016-08-15 00:00:00

  • AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells.

    abstract::Myeloid-derived suppressor cells (MDSC) represent a primary mechanism of immune evasion in tumors and have emerged as a major obstacle for cancer immunotherapy. The immunoinhibitory activity of MDSC is tightly regulated by the tumor microenvironment and occurs through mechanistic mediators that remain unclear. Here, w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-0880

    authors: Trillo-Tinoco J,Sierra RA,Mohamed E,Cao Y,de Mingo-Pulido Á,Gilvary DL,Anadon CM,Costich TL,Wei S,Flores ER,Ruffell B,Conejo-Garcia JR,Rodriguez PC

    更新日期:2019-10-01 00:00:00

  • High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas.

    abstract::Human B-cell lymphomas are frequently associated with specific genetic changes caused by chromosomal translocations that activate proto-oncogenes. For lymphomas of mice expressing murine leukemia virus, mutagenic proviral insertions are thought to play a similar role. Here we report studies designed to determine wheth...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-03-3885

    authors: Shin MS,Fredrickson TN,Hartley JW,Suzuki T,Akagi K,Morse HC 3rd

    更新日期:2004-07-01 00:00:00

  • The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.

    abstract::Breast carcinomas < or = 1 cm in size (T1a,b) are being detected more frequently as a result of screening. Because traditional prognostic parameters are either lacking (tumor size) or rare (nodal metastases), a marker(s) is needed to identify the subset of patients who could benefit from adjuvant therapy. A retrospect...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tan P,Cady B,Wanner M,Worland P,Cukor B,Magi-Galluzzi C,Lavin P,Draetta G,Pagano M,Loda M

    更新日期:1997-04-01 00:00:00

  • Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.

    abstract::Intravesical mitomycin C (MMC) therapy is used to treat superficial bladder cancer. This study was to establish the intra- and intersubject variabilities in the systemic (plasma) and target site (bladder) exposure to the drug and to identify the factors which contribute to these variabilities. The pharmacokinetics of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dalton JT,Wientjes MG,Badalament RA,Drago JR,Au JL

    更新日期:1991-10-01 00:00:00

  • Tumor-associated membrane sialoglycoprotein on human small cell lung carcinoma identified by the IgG2a monoclonal antibody SWA20.

    abstract::A mouse IgG2a monoclonal antibody, SWA20, defining a tumor-associated cell surface antigen on small cell carcinoma of the lung (SCC) was generated. The reactivity of the antibody with cell lines was examined by indirect immunofluorescence staining and solid phase radioimmunoassay and the reactivity with tissues by imm...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Waibel R,O'Hara CJ,Smith A,Stahel RA

    更新日期:1988-08-01 00:00:00

  • Immunohistochemical analysis of human pulmonary carcinomas using monoclonal antibody 44-3A6.

    abstract::A monoclonal antibody, 44-3A6, was raised against the human pulmonary adenocarcinoma cell line A549. This antibody recognizes a protein antigen at the cell surface, which is preserved after formalin fixation and paraffin embedding. Immunohistochemical staining of lung tissue with this antibody revealed diffuse immunor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lee I,Radosevich JA,Ma YX,Combs SG,Rosen ST,Gould VE

    更新日期:1985-11-01 00:00:00

  • Hormonal treatment after cytotoxic therapy stimulates recovery of spermatogenesis.

    abstract::Previous studies have shown that treatment of rats with gonadotropin-releasing hormone (GnRH) analogues or steroids either before exposure to procarbazine or radiation or after irradiation enhances subsequent levels of spermatogenesis. We demonstrate here that giving a GnRH agonist after procarbazine injection also en...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Meistrich ML,Wilson G,Huhtaniemi I

    更新日期:1999-08-01 00:00:00

  • Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity.

    abstract::Ongoing clinical trials are exploring anticancer approaches based on signaling by TRAIL, a ligand for the cell death receptors DR4 and DR5. In this study, we report on the selective apoptotic effects of multivalent DR5 binding peptides (TRAIL(mim/DR5)) on cancer cells in vitro and in vivo. Surface plasmon resonance re...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2889

    authors: Pavet V,Beyrath J,Pardin C,Morizot A,Lechner MC,Briand JP,Wendland M,Maison W,Fournel S,Micheau O,Guichard G,Gronemeyer H

    更新日期:2010-02-01 00:00:00

  • Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.

    abstract::Epidemiological studies have shown a positive association of colon cancer with hyperlipidemia. Furthermore, signaling generated by peroxisome proliferator-activated receptor (PPAR) alpha and gamma ligands, suggested to be candidate tumor preventive agents, has been shown to lower serum triglyceride levels. In the pres...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Niho N,Takahashi M,Kitamura T,Shoji Y,Itoh M,Noda T,Sugimura T,Wakabayashi K

    更新日期:2003-09-15 00:00:00

  • Insertional mutagenesis reveals progression genes and checkpoints in MYC/Runx2 lymphomas.

    abstract::In this study, we have exploited the power of insertional mutagenesis to elucidate tumor progression pathways in mice carrying two oncogenes (MYC/Runx2) that collaborate to drive early lymphoma development. Neonatal infection of these mice with Moloney murine leukemia virus resulted in accelerated tumor onset with ass...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0433

    authors: Stewart M,Mackay N,Hanlon L,Blyth K,Scobie L,Cameron E,Neil JC

    更新日期:2007-06-01 00:00:00

  • Cytotoxicity of human beta-interferon for differentiating leukemic HL-60 cells.

    abstract::We examined the effect of human interferon (HuIFN) -alpha and -beta on the proliferation and differentiation induced by dimethyl sulfoxide (DMSO) of HL-60 human promyelocytic leukemia cells into mature granulocytes. Neither HuIFN-alpha nor -beta, alone, from 1 to 1000 IU/ml, nor the homologous mock HuIFN preparations ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hamburger AW,White CP,Siebenlist RE,Sedmak JJ,Grossberg SE

    更新日期:1985-11-01 00:00:00